ASML: Q2 Pulled The Earnings Story Forward

Analyst reiterates a Buy on ASML and raises the price target to $2,510 from $2,173. For 2026, revenue guidance midpoint increases from €38B to €44B and gross margin midpoint from 52% to 55%. The note lifts estimates to ~€38 EPS for 2026 and €42.40 for 2027, citing growth across EUV/DUV/High NA and Installed Base Management.

Analysis

This is less a one-quarter upgrade than a validation that leading-edge capacity spending is still being pulled through by AI/foundry bottlenecks. The second-order read-through is broader than ASML: if the bottleneck supplier is confident enough to lift its 2026 margin trajectory, then the capex plans of TSM, Samsung, and Intel are likely still intact, which should keep the WFE complex from de-rating on “peak spend” fears. That also supports high-multiple semiconductor beneficiaries that depend on sustained node transitions rather than one-time demand spikes.

The margin step-up matters because it signals pricing/mix power, not just units. If High NA ramps with limited execution slippage, earnings can compound faster than revenue and justify a premium multiple; if not, the market will punish the stock for any hint that the long-duration backlog is less durable than assumed. The near-term catalyst path is mostly order commentary and customer capex updates over the next 1-3 quarters; the structural story plays out over 6-18 months as installed base revenue becomes a larger share of profit.

Consensus is probably not missing the upside, but may be underestimating how sensitive the setup is to policy and customer timing. A single China/export-control surprise or a delay in EUV/High NA qualification can reverse the narrative quickly because the stock is now priced for multi-year visibility. Conversely, if ASML keeps compounding while broader semis stall, it should continue to take share as the highest-quality expression of AI infrastructure spend.

Key Decisions for Investors

• Buy ASML on 3-5% pullbacks over the next 1-2 weeks; target a 10-15% move over 3-6 months if 2026 order commentary stays constructive. Falsify on any deceleration in bookings or margin guidance below the new midpoint.
• Pair trade: long ASML / short SOXX into the next semi earnings season to isolate the highest-visibility WFE compounder from broader sector beta. Thesis breaks if SOXX keeps outperforming on a new AI capex leg or if ASML order intake rolls over.
• Add to a basket of semicap names with operating leverage to continued node transitions, especially KLAC and AMAT, but only on confirmation that foundry/logic capex budgets remain intact. Watch for customer capex cuts or delayed tool acceptance as the main downside trigger.
• Set a tactical alert for any China/export-control headlines or order-book revisions; those are the cleanest reversal catalysts and likely matter more than macro data in the next 1-3 months.